Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
Company to showcase next-generation PCIe 6.0 CopprLinkâ„¢ cable adapters and new 4UPro-Max expansion accelerator for ultra-low latency, high-wattage AI workloads at Booth 2111 Latest innovation from OSS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback